Literature DB >> 11395368

Differential loss of chromosome 11q in familial and sporadic parasympathetic paragangliomas detected by comparative genomic hybridization.

H Dannenberg1, R R de Krijger, J Zhao, E J Speel, P Saremaslani, W N Dinjens, W J Mooi, J Roth, P U Heitz, P Komminoth.   

Abstract

Parasympathetic paragangliomas (PGLs) represent neuroendocrine tumors arising from chief cells in branchiomeric and intravagal paraganglia, which share several histological features with their sympathetic counterpart sympathoadrenal paragangliomas. In recent years, genetic analyses of the familial form of PGL have attracted considerable interest. However, the majority of paragangliomas occurs sporadically and it remains to be determined whether the pathogenesis of sporadic paraganglioma resembles that of the familial form. Furthermore, data on comparative genetic aberrations are scarce. To provide fundamental cytogenetic data on sporadic and hereditary PGLs, we performed comparative genomic hybridization using directly fluorochrome-conjugated DNA extracted from 12 frozen and 4 paraffin-embedded tumors. The comparative genomic hybridization data were extended by loss of heterozygosity analysis of chromosome 11q. DNA copy number changes were found in 10 (63%) of 16 tumors. The most frequent chromosomal imbalance involved loss of chromosome 11. Six of seven familial tumors and two of nine sporadic tumors showed loss of 11q (86% versus 22%, P = 0.012). Deletions of 11p and 5p were found in two of nine sporadic tumors. We conclude that overall DNA copy number changes are infrequent in PGLs compared to sympathetic paragangliomas and that loss of chromosome 11 may be an important event in their tumorigenesis, particularly in familial paragangliomas.

Entities:  

Mesh:

Year:  2001        PMID: 11395368      PMCID: PMC1891979          DOI: 10.1016/S0002-9440(10)64662-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory.

Authors:  A G van der Mey; P D Maaswinkel-Mooy; C J Cornelisse; P H Schmidt; J J van de Kamp
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

3.  Expression of angiogenic growth factors in paragangliomas.

Authors:  R W Jyung; E E LeClair; R A Bernat; T S Kang; F Ung; M J McKenna; R S Tuan
Journal:  Laryngoscope       Date:  2000-01       Impact factor: 3.325

4.  Familial concurrence of carotid body tumor and pheochromocytoma.

Authors:  J W Pritchett
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

5.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Authors:  E Edström; E Mahlamäki; B Nord; M Kjellman; R Karhu; A Höög; N Goncharov; B T Teh; M Bäckdahl; C Larsson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

Authors:  S Niemann; U Müller
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence.

Authors:  J A Carney
Journal:  Mayo Clin Proc       Date:  1999-06       Impact factor: 7.616

8.  Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients.

Authors:  E E Lack; A L Cubilla; J M Woodruff
Journal:  Hum Pathol       Date:  1979-03       Impact factor: 3.466

9.  Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia.

Authors:  L M DeAngelis; M B Kelleher; K D Post; M R Fetell
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

10.  DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours).

Authors:  A G van der Mey; C J Cornelisse; J Hermans; J L Terpstra; P H Schmidt; G J Fleuren
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more
  12 in total

Review 1.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

Review 2.  Rethinking pheochromocytomas and paragangliomas from a genomic perspective.

Authors:  L J Castro-Vega; C Lepoutre-Lussey; A-P Gimenez-Roqueplo; J Favier
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

Review 4.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 5.  Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Authors:  Aoife J Lowery; Siun Walsh; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-04-10

Review 6.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

Review 7.  Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.

Authors:  Erik F Hensen; Jean-Pierre Bayley
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

8.  LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma.

Authors:  Hai-Yan Sun; Bin Cui; Din-Wei Su; Xiao-Long Jin; Fu-Kang Sun; Yu Zu; Lei Jiang; Wei-Qing Wang; Guang Ning
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

9.  Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.

Authors:  Erik F Hensen; Jelle J Goeman; Jan Oosting; Andel G L Van der Mey; Pancras C W Hogendoorn; Cor W R J Cremers; Peter Devilee; Cees J Cornelisse
Journal:  BMC Med Genomics       Date:  2009-05-11       Impact factor: 3.063

10.  Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.

Authors:  Jean-Pierre Bayley; Rogier A Oldenburg; Jennifer Nuk; Attje S Hoekstra; Conny A van der Meer; Esther Korpershoek; Barbara McGillivray; Eleonora P M Corssmit; Winand N M Dinjens; Ronald R de Krijger; Peter Devilee; Jeroen C Jansen; Frederik J Hes
Journal:  BMC Med Genet       Date:  2014-10-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.